H Kalant

Summary

Affiliation: University of Toronto
Country: Canada

Publications

  1. ncbi Smoked marijuana as medicine: not much future
    H Kalant
    Department of Pharmacology, University of Toronto, Toronto, Ontario, Canada
    Clin Pharmacol Ther 83:517-9. 2008
  2. ncbi The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs
    H Kalant
    Department of Pharmacology, University of Toronto, Addiction Research Foundation Division, Centre for Addiction and Mental Health, Toronto, Ont
    CMAJ 165:917-28. 2001
  3. ncbi Medicinal use of cannabis: history and current status
    H Kalant
    Department of Pharmacology, University of Toronto, Toronto, Ontario, Canada
    Pain Res Manag 6:80-91. 2001
  4. ncbi Adverse effects of cannabis on health: an update of the literature since 1996
    Harold Kalant
    Department of Pharmacology, Medical Sciences Building, University of Toronto, Toronto, ON, Canada M5S 1A8
    Prog Neuropsychopharmacol Biol Psychiatry 28:849-63. 2004
  5. ncbi Drug treatment--not as useless as it seems
    Harold Kalant
    University of Toronto, Canada
    Addiction 103:707-8; discussion 710. 2008
  6. ncbi What neurobiology cannot tell us about addiction
    Harold Kalant
    Department of Pharmacology, University of Toronto, Toronto, Canada
    Addiction 105:780-9. 2010
  7. ncbi Drug classification: science, politics, both or neither?
    Harold Kalant
    Department of Pharmacology, University of Toronto, and Centre for Addiction and Mental Health, Toronto, Canada
    Addiction 105:1146-9. 2010

Detail Information

Publications7

  1. ncbi Smoked marijuana as medicine: not much future
    H Kalant
    Department of Pharmacology, University of Toronto, Toronto, Ontario, Canada
    Clin Pharmacol Ther 83:517-9. 2008
  2. ncbi The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs
    H Kalant
    Department of Pharmacology, University of Toronto, Addiction Research Foundation Division, Centre for Addiction and Mental Health, Toronto, Ont
    CMAJ 165:917-28. 2001
    ..The toxic or even fatal dose range overlaps the range of recreational dosage. The available evidence does not yet permit an accurate assessment of the size of the problem presented by the use of these drugs...
  3. ncbi Medicinal use of cannabis: history and current status
    H Kalant
    Department of Pharmacology, University of Toronto, Toronto, Ontario, Canada
    Pain Res Manag 6:80-91. 2001
    ..To provide an overview of the history and pharmacology of cannabis in relation to current scientific knowledge concerning actual and potential therapeutic uses of cannabis preparations and pure cannabinoids...
  4. ncbi Adverse effects of cannabis on health: an update of the literature since 1996
    Harold Kalant
    Department of Pharmacology, Medical Sciences Building, University of Toronto, Toronto, ON, Canada M5S 1A8
    Prog Neuropsychopharmacol Biol Psychiatry 28:849-63. 2004
    ..In total, the evidence indicates that regular heavy use of cannabis carries significant risks for the individual user and for the health care system...
  5. ncbi Drug treatment--not as useless as it seems
    Harold Kalant
    University of Toronto, Canada
    Addiction 103:707-8; discussion 710. 2008
  6. ncbi What neurobiology cannot tell us about addiction
    Harold Kalant
    Department of Pharmacology, University of Toronto, Toronto, Canada
    Addiction 105:780-9. 2010
    ....
  7. ncbi Drug classification: science, politics, both or neither?
    Harold Kalant
    Department of Pharmacology, University of Toronto, and Centre for Addiction and Mental Health, Toronto, Canada
    Addiction 105:1146-9. 2010
    ..The problems inherent in such drug classification are illustrated by the examples of cannabis and of salvinorin A. They raise the question as to whether the classification process really serves any socially beneficial purpose...